RYI Insider Kannan Molly D Files Form 4 on March 19, 2026
| Field | Detail |
|---|---|
| Company | Kannan Molly D |
| Form Type | 4 |
| Filed Date | Mar 23, 2026 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-filing, form-4, ownership-change
Related Tickers: RYI
TL;DR
**RYI insider filed a Form 4, watch for transaction details.**
AI Summary
This Form 4 filing indicates that Kannan Molly D, an insider at Ryerson Holding Corp (RYI), reported a transaction on March 19, 2026. While the filing details are not fully provided in the snippet, a Form 4 typically discloses changes in beneficial ownership of company securities by insiders. This matters to investors because insider transactions can signal management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock price.
Why It Matters
Insider transactions, like those reported on a Form 4, can provide clues about how company executives and directors view the company's value and future performance.
Risk Assessment
Risk Level: medium — Without the specific transaction details (buy/sell, quantity, price), the impact of this filing is currently unknown, posing a medium risk for misinterpretation.
Analyst Insight
An investor should look for the full Form 4 document to understand the nature of the transaction (buy or sell, quantity, price) before making any investment decisions, as this snippet only confirms the filing occurred.
Key Players & Entities
- Kannan Molly D (person) — Reporting Person
- Ryerson Holding Corp (company) — Issuer
- 0001799091 (person) — Kannan Molly D's CIK
- 0001481582 (company) — Ryerson Holding Corp's CIK
- 2026-03-19 (date) — Period of Report
FAQ
What specific transaction did Kannan Molly D report in this Form 4 filing?
The provided filing snippet indicates that Kannan Molly D, an insider for Ryerson Holding Corp, filed a Form 4 for the period of report March 19, 2026. However, the snippet does not contain the specific details of the transaction, such as whether it was a purchase or sale, the number of shares, or the price.
What is the business address of Ryerson Holding Corp?
Ryerson Holding Corp's business address is 227 W. MONROE ST., 27TH FLOOR, CHICAGO IL 60606.
Filing Stats: 862 words · 3 min read · ~3 pages · Grade level 7.7 · Accepted 2026-03-23 17:15:42
Filing Documents
- form4.html (4)
- form4.xml (4) — 9KB
- 0000899140-26-000343.txt ( ) — 11KB
From the Filing
SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Kannan Molly D (Last) (First) (Middle) C/O RYERSON HOLDING CORPORATION 227 W. MONROE ST., 27TH FLOOR (Street) CHICAGO ILLINOIS 60606 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Ryerson Holding Corp [ RYZ ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) CAO & Corporate Controller 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/19/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Units (1) 03/19/2026 A 19.457 (2) (3) (3) Common Stock 19.457 $ 0 2,109.309 D Restricted Stock Units (1) 03/19/2026 A 38.058 (2) (4) (4) Common Stock 38.058 $ 0 4,125.959 D Restricted Stock Units (1) 03/19/2026 A 62.959 (2) (5) (5) Common Stock 62.959 $ 0 6,825.55 D Explanation of Responses: 1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). 2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. 3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026. 4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027. 5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028. /s/ Camilla Rykke Merrick, attorney-in-fact 03/23/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by mo